
Novel Drug Approvals for 2025 | FDA
4 days ago · What are "Novel" Drugs? "Novel" drugs are new drugs never before approved or marketed in the U.S. See Drugs@FDA for information about all of CDER’s approved drugs and biological …
New FDA Drug Approvals for 2025 - Drugs.com
4 days ago · Up to date information on the latest FDA drug approvals. Includes list of most recent approvals, the conditions approved for, and the approval history.
FDA Drug Approvals 2025: Full List of 28 New Therapies - GreyB
Explore the full list of 2025 FDA drug approvals, 28 new therapies across oncology, rare disease, and more.
FDA New Drug Approvals: The 14 Biggest Approvals of 2025 So Far - GoodRx
Oct 3, 2025 · This list highlights notable medications and vaccines that have been FDA approved so far in 2025. They represent major advancements compared to other available treatment options.
Mid-Year Roundup: FDA’s Novel Retail and Specialty Drug Approvals in 2025
Jun 26, 2025 · Explore the latest FDA-approved novel drugs transforming treatment options for various conditions, enhancing patient care and outcomes in community and specialty pharmacy.
MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025
6 days ago · Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.
FDA new drug approvals in Q3 2025 - Nature
Oct 13, 2025 · The third quarter of 2025 delivered a welcome bolus of novel FDA drug approvals, with the 16 approvals in the quarter matching the 16 approvals in total in the first half of the year...
Standout drug approvals in 2025 | PharmaVoice
Dec 8, 2025 · Several upcoming PDUFA dates this month could also boost the novel drug approval rate before the year’s out. For now, here’s a look at some of the standout approvals in 2025.
Recent and anticipated novel drug approvals (3Q 2025 through 2Q …
Aug 29, 2025 · Summary Selected drug approvals anticipated in the 12-month period covering the third quarter of 2025 through the second quarter of 2026 are reviewed. The analysis emphasizes drugs …
Q2 2025 Recap: Top FDA Approvals - HCPLive
Jul 6, 2025 · The second quarter of 2025 delivered a wave of impactful FDA approvals across a spectrum of rare and chronic diseases, expanding treatment options and advancing precision medicine.